UBS Maintains Neutral on Accenture, Raises Price Target to $365
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Kevin Mcveigh has maintained a Neutral rating on Accenture (NYSE:ACN) and increased the price target from $333 to $365.
December 20, 2023 | 3:46 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS analyst Kevin Mcveigh maintains a Neutral rating on Accenture but raises the price target from $333 to $365.
The increase in price target by UBS suggests a positive reassessment of Accenture's value, which could lead to increased investor confidence and a potential short-term rise in the stock price. However, the Neutral rating indicates that the analyst does not see significant upside or downside potential from the current level, which tempers the impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100